Methods of reducing T cell-mediated immune responses with multimeric P-selectin and/or E-selectin compounds
    4.
    发明授权
    Methods of reducing T cell-mediated immune responses with multimeric P-selectin and/or E-selectin compounds 有权
    用多聚体P-选择蛋白和/或E-选择素化合物降低T细胞介导的免疫应答的方法

    公开(公告)号:US08628775B2

    公开(公告)日:2014-01-14

    申请号:US12562515

    申请日:2009-09-18

    IPC分类号: A61K38/17 C07K14/435

    摘要: Multimeric compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion and/or to induce T cell or NK cell apoptosis. The multimeric compounds and methods of the invention can be used to control unwanted T cell- or NK cell-mediated immune responses in conditions such as inflammatory diseases, autoimmune diseases, transplant rejection, and allergic diseases.

    摘要翻译: 可以将T细胞或天然杀伤(NK)细胞表面上结合P-选择蛋白糖蛋白1(PSGL-1)的多聚体化合物诱导T细胞或NK细胞消耗和/或诱导T细胞或NK细胞凋亡 。 本发明的多聚体化合物和方法可用于在诸如炎性疾病,自身免疫疾病,移植排斥反应和过敏性疾病的病症中控制不需要的T细胞或NK细胞介导的免疫应答。

    MODULATORS OF P-SELECTIN GLYCOPROTEIN LIGAND 1
    10.
    发明申请
    MODULATORS OF P-SELECTIN GLYCOPROTEIN LIGAND 1 有权
    P-选择素GLYCOPROTEIN配体的调节剂1

    公开(公告)号:US20100080819A1

    公开(公告)日:2010-04-01

    申请号:US12562515

    申请日:2009-09-18

    摘要: Multimeric compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion and/or to induce T cell or NK cell apoptosis. The multimeric compounds and methods of the invention can be used to control unwanted T cell- or NK cell-mediated immune responses in conditions such as inflammatory diseases, autoimmune diseases, transplant rejection, and allergic diseases.

    摘要翻译: 可以将T细胞或天然杀伤(NK)细胞表面上结合P-选择蛋白糖蛋白1(PSGL-1)的多聚体化合物诱导T细胞或NK细胞消耗和/或诱导T细胞或NK细胞凋亡 。 本发明的多聚体化合物和方法可用于在诸如炎性疾病,自身免疫疾病,移植排斥反应和过敏性疾病的病症中控制不需要的T细胞或NK细胞介导的免疫应答。